# Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ramucirumab-plus-docetaxel-versus-placebo-plus-docetaxel-for-second-line/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Edward B. Garon,Tudor–Eliade Ciuleanu,Óscar Arrieta,Kumar Prabhash,Konstantinos N. Syrigos,Tuncay Göksel,Keunchil Park,Vera Gorbunova,Rubén Dario Kowalyszyn,Joanna Pikiel,Grzegorz Czyżewicz,С. В. Орлов,C. Lewanski,Michael Thomas,Paolo Bidoli,Shaker R. Dakhil,Steven Gans,Joo-Hang Kim,Alexandru Grigorescu,Nina Karaseva,Martin Reck,Federico Cappuzzo,Ekaterine Alexandris,Andreas Sashegyi,Sergey Yurasov,M. Pérol |
| Citations | 1,312 |
| DOI | 10.1016/s0140-6736(14)60845-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://www.sciencedirect.com/science/article/pii/S014067361460845X |
| OpenAlex ID | https://openalex.org/W2140980839 |
| PMID | 24933332 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Edward B. Garon](https://scholariq.org/researchers/edward-b-garon/)
- [Keunchil Park](https://scholariq.org/researchers/keunchil-park/)
- [Kumar Prabhash](https://scholariq.org/researchers/kumar-prabhash/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.